Table 2.
Cancer Type | Sample/Model System | Mechanism | Expression | Reference |
---|---|---|---|---|
Prostate cancer | poorly metastatic and highly metastatic variant of human prostate cancer cell lines and primary cancer tissues | promoter hypermethylation | loss of LDHB expression | [51] |
Gastric cancer cell lines and pancreatic cancer | four gastric cancer cell lines and one pancreatic cancer cell line | promoter hypermethylation | loss of LDHB expression, loss of LDH1-4 | [52] |
Pancreatic cancer | pancreatic cancer tissues and cell lines | promoter hypermethylation | suppressed LDHB and even total loss | [53] |
Breast cancer | breast cancer (adenocarcinoma) tissues and cell lines | promoter hypermethylation | Absent or decreased expression of LDH isoenzymes 1–4 | [54] |
Breast cancer | basal-like/triple-negative breast cancers | glycolytic pathway | high LDHB expression | [55] |
Hepatocellular carcinoma | Highly metastatic cell line | Metastasis potential | down-regulated LDHB expression | [56] |
Hepatocellular carcinoma | HCC cancer tissues | unfavorable survival outcomes | Low LDHB expression | [57] |
Urinary bladder urothelial carcinoma (UBUC) | UBUC cancer tissues | tumor progression and inferior disease-specific survival | Loss of LDHB expression | [58] |
Colorectal cancer | colorectal cancer tissues, in vitro and in vivo model |
increased autophagy, accelerated cancer growth mediated by SIRT5/LDHB pathway | Deacetylation of LDHB | [61] |
Colorectal cancer | colorectal cancer tissues, CRC cell lines, |
RPS7 mediated cell glycolysis inhibition, inhibits colorectal cancer growth | Suppressed LDHB expression | [62] |
Hepatoma cancer | hepatoma cell lines | claudin-1-mediated high invasive activity | Decreased LDHB expression | [63] |
Colorectal cancer | stage I-III CRC patient samples, in vitro | KLF14 regulates glycolysis | downregulating LDHB expression | [64] |
Lung cancer | KRAS-dependent lung adenocarcinoma samples, vitro and in vivo | predictor of shorter survival in patients, KRAS-mutant lung tumors are more dependent on glycolysis for proliferation compared with KRAS wild-type lung tumors | high LDHB expression | [65] |